CWM
IMGN

Cedar Wealth Management’s Immunogen Inc IMGN Stock Holding History

Cedar Wealth Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-112
Closed -$1K – 151
2017
Q3 		$1K Hold
112
– – ﹤0.01% 134
2017
Q2 		$1K Hold
112
– – ﹤0.01% 137
2017
Q1 		$0 Hold
112
– – ﹤0.01% 140
2016
Q4 		$0 Hold
112
– – ﹤0.01% 136
2016
Q3 		$0 Hold
112
– – ﹤0.01% 127
2016
Q2 		$0 Buy
+112
New +$702 ﹤0.01% 146

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cedar Wealth Management's IMGN Position: Q4 2017 in Review

Cedar Wealth Management sold out of Immunogen Inc (IMGN) in Q4 2017, closing a stake of 112 shares — an estimated $1K sold.

Cedar Wealth Management first reported a position in IMGN in Q2 2016 and held it in 6 quarters. The position peaked at $1K in Q3 2017. 200 funds tracked by Wall St. Rank hold IMGN as of Q4 2017.

  • Cedar Wealth Management reported no remaining Immunogen Inc position as of Q4 2017 after selling out during the quarter.
  • Cedar Wealth Management sold 112 Immunogen Inc shares in Q4 2017, an estimated $1K.
  • Cedar Wealth Management first reported a position in Immunogen Inc in Q2 2016 and held it in 6 quarters.
  • Cedar Wealth Management's Immunogen Inc position peaked at $1K in Q3 2017.
  • 200 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2017.

Based on Cedar Wealth Management's 13F filing for Q4 2017, filed 2 Feb 2018.